Incision Choice for Transthoracic Device Closure of Ventricular Septal Defect: Reply.
Transthoracic Device Closure, Transcatheter Device Closure, and Surgical Repair via Right Submammary Thoracotomy for Restrictive Ventricular Septal Defect, a Respective Comparative Study.
Direct Percutaneous Repair of Left Ventricular Pseudoaneurysm via Transthoracic Deployment of a Ventricular Septal Defect Closure Device.
Hybrid Transthoracic Periventricular Device Closure of Ventricular Septal Defects: Single- Center Experience.
Wu L, Tanidir IC, Ye D, Zhang X, Li B, Zhu D, Deng G, Chen H.
Braz J Cardiovasc Surg. 2021 Feb 1;36(1):48-56. doi: 10.21470/1678-9741-2020-0115.
Device Closure of Perimembranous Ventricular Septal Defect: Choosing Between Amplatzer Occluders.
Haddad RN, Daou L, Saliba Z.
Front Pediatr. 2019 Aug 16;7:300. doi: 10.3389/fped.2019.00300. eCollection 2019.
Transthoracic device closure of perimembranous ventricular septal defect via a small left intercostal incision in children.
Xie L, Zhang G, He J, Shen Y, Liao D, Chen L, Xu F.
Front Cardiovasc Med. 2023 Aug 21;10:1221136. doi: 10.3389/fcvm.2023.1221136. eCollection 2023.
Transcatheter closure of perimembranous ventricular septal defect using a novel fully bioabsorbable occluder: multicenter randomized controlled trial.
Wang S, Li Z, Wang Y, Zhao T, Mo X, Fan T, Li J, You T, Deng R, Ouyang W, Wang W, Zhang C, Butera G, Hijazi ZM, Pang K, Zhu D, Jiang S, Zhang G, Hu X, Xie Y, Zhang F, Fang F, Sun J, Li P, Chen J, Luo Z, Pan X.
Sci Bull (Beijing). 2023 May 30;68(10):1051-1059. doi: 10.1016/j.scib.2023.04.027. Epub 2023 Apr 26.
Transcatheter Device Closure of Perimembranous Ventricular Septal Defect in Pediatric Patients: Long-Term Outcomes.
Shah JH, Saraiya SP, Nikam TS, Jha MJ.
Heart Views. 2020 Jan-Mar;21(1):17-21. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_13_19. Epub 2020 Jan 23.
Transthoracic Device Closure of Juxtaarterial Ventricular Septal Defects: Midterm Follow-Up Results.
Song X, Xing Q, Wu Q, Ren Y, Wan H, Li J.
Ann Thorac Surg. 2017 Sep;104(3):841-846. doi: 10.1016/j.athoracsur.2017.01.042. Epub 2017 Mar 31.
Effects of transthoracic device closure on ventricular septal defects and reasons for conversion to open-heart surgery: A meta-analysis.
Zhou Y, Liu LX, Zhao F, Tang SH, Peng HL, Jiang YH.
Sci Rep. 2017 Sep 22;7(1):12219. doi: 10.1038/s41598-017-12500-6.
Favorable mid-term performance of fully biodegradable implantable device for ventricular septal defect closure.
Song S, Shao Z, Fan T, Li B, Liang W, Dong H, Wu K, Hu M, Han Y, Cui C.
JTCVS Tech. 2022 Dec 10;17:133-137. doi: 10.1016/j.xjtc.2022.11.010. eCollection 2023 Feb.
Perventricular device closure of perimembranous ventricular septal defect: effectiveness of symmetric and asymmetric occluders.
Ou-Yang WB, Wang SZ, Hu SS, Zhang FW, Zhang DW, Liu Y, Meng H, Pang KJ, Meng LK, Pan XB.
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):478-482. doi: 10.1093/ejcts/ezw352.
Transthoracic closure of atrial septal defect and ventricular septal defect without cardiopulmonary bypass.
Wan L, Yu BT, Wu QC, Zeng L, Wang Q, Tang J, Xu QR, Xu H, Wang WJ, Cao YP, Liu JC.
Genet Mol Res. 2015 Apr 22;14(2):3760-6. doi: 10.4238/2015.April.22.4.
